紫光國微(002049.SZZ)一度跌停 中誠信國際將公司主體信用等級列入觀察名單
格隆匯11月13日丨紫光國微(002049.SZZ)早盤一度跌停報92.72元,創今年7月初以來新低,目前跌幅略收窄至8.85%報93.9元,市值571億元。近期紫光系債券出現連續下跌,公司今早公告,中誠信國際決定將紫光國微AA+的主體信用等級列入觀察名單;將“18國微01”的債項信用等級由AAA調降至AA+,撤出可能降級的觀察名單,並列入觀察名單。此外,“18國微01”公司債券將在11月13日至11月16日停牌兩天,11月17日開市起復牌。自復牌之日起,“18國微01”公司債券交易實施投資者適當性安排,僅限合格機構投資者參與交易。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.